Uri Weinberg is CSO at NovoCure Ltd (NVCR). They have made 9 open-market trades across 1 company since 2020, most recently 2026-03-04.
CIK 0001811030
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 267,190 | $3.9M |
Shares reported on the most recent Form 4, priced at the 2026-03-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2026-03-04 | 2026-03-05 | $13.31 | $85K | -9.5% | -22.8% | +18.5% |
| NVCR | SELL | 2026-02-27 | 2026-03-03 | $13.68 | $147K | -8.5% | -20.0% | +25.6% |
| NVCR | SELL | 2025-03-03 | 2025-03-04 | $18.92 | $5K | +7.9% | -6.0% | -5.7% |
| NVCR | SELL | 2025-02-28 | 2025-03-03 | $18.76 | $168K | +13.1% | +1.1% | -3.9% |
| NVCR | SELL | 2023-01-05 | 2023-01-09 | $116.14 | $946K | -3.3% | -1.5% | -30.3% |
| NVCR | SELL | 2021-05-10 | 2021-05-12 | $189.65 | $2.1M | +1.9% | +18.9% | -21.8% |
| NVCR | SELL | 2021-03-23 | 2021-04-09 | $140.00 | $397K | +54.0% | +39.7% | +47.2% |
| NVCR | SELL | 2021-02-22 | 2021-02-24 | $175.50 | $1.1M | -25.7% | -27.2% | +9.9% |
| NVCR | SELL | 2020-09-25 | 2020-09-28 | $103.35 | $2.5M | +18.9% | +6.1% | +56.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.